Experimental Drug Promising Against Tough-to-Treat Asthma – U.S. News & World Report

Experimental Drug Promising Against Tough-to-Treat Asthma
U.S. News & World Report
3 (HealthDay News) — A new experimental drug for adults with asthma seems to improve lung function in patients who haven't been helped with standard steroids. The drug, lebrikizumab, targets a specific receptor involved in asthma, and appears to be
Lebrikizumab Ups Lung Function in Adults With AsthmaDoctors Lounge
Lebrikizumab Improves Lung Function in AsthmaMedscape
Roche asthma drug shows promise in mid-stage trialReuters
Fox Business –MedPage Today –InPharm
all 23 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.